Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris

ClinicalTrials.gov ID: NCT01347879

Public ClinicalTrials.gov record NCT01347879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PCTA206/11 A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi Center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is intended to evaluate the efficacy and safety of Visonac Photodynamic Therapy (PDT) in patients with severe acne, score 4 on global IGA scale. The null hypothesis is that Visonac PDT is equal to vehicle PDT against the alternative hypothesis that Visonac PDT is different compared to vehicle PDT at week 12.

Study identification

NCT ID
NCT01347879
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Photocure
Industry
Enrollment
153 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 35 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Mar 31, 2012
Completion
Apr 30, 2012
Last update posted
Jan 15, 2014

2011 – 2012

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Dermatology Specialists Inc Oceanside California 92056
Rady Children's Hospital San Diego California 92123
North Florida Dermatology Associates Jacksonville Florida 32204
Altman Dermatology Associates Arlington Heights Illinois 60005
Dermatology Institute, DuPage Medical Group Naperville Illinois 60563
Deaconess Clinic Inc Evansville Indiana 47713
ActivMed Practices & Research Inc Haverhill Massachusetts 10830
Hamzavi Dermatology Fort Gratiot Michigan 48059
Somerset Skin Centre Troy Michigan 48084
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Clinical Partners LLC Johnston Rhode Island 02919
DermResearch Inc Austin Texas 78759
Clinical Trials of Texas San Antonio Texas 78229
Virginia Clinical Research, Inc. Norfolk Virginia 23507
Premier Clinical Research Spokane Washington 99216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01347879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2014 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01347879 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →